Delcath Systems, HEPZATO KIT

Melphalan inotenderwa neFDA semushonga unotungamirwa nechiropa kune uveal melanoma

Nov 2023: The Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) as a liver-directed treatment for adult patients with uveal melanoma who have unresectable h..

China, Clinical trials, hepatocellular carcinoma, JW Therapeutics, Shanghai

JW Therapeutics Inozivisa Kutanga kweClinical Study yeJWATM214 muVarwere vane Advanced Hepatocellular Carcinoma.

SHANGHAI, CHINA, Kukadzi 28, 2023 - JW Therapeutics (HKEX: 2126), yakazvimiririra uye inovandudza biotechnology kambani inotarisana nekugadzira, kugadzira uye kutengesa zvigadzirwa zvema cell immunotherapy, yakazivisa iyo init.

durvalumab, hepatocellular carcinoma, tremelimumab

Tremelimumab inotenderwa neFDA pamwe chete nedurvalumab kune isingagadziriswe hepatocellular carcinoma.

November 2022: The Food and Drug Administration approved tremelimumab (Imjudo, AstraZeneca Pharmaceuticals) in combination with durvalumab for adult patients with unresectable hepatocellular carcinoma (uHCC). Efficacy was evaluat..

Atezolizumab, Bevacizumab, nivolumab, Regorafenib, Stivarga, Tecentriq

Mishonga inotenderwa kurapa gomarara rechiropa

Zvita 2021: Mishonga inotevera inotenderwa semazuvano ekurapa cancer yechiropa:. Ndokumbira utarise ruzivo rwekuraira usati watora mushonga. Atezolizumab Avastin (Bevacizumab) Bevacizumab Cabometyx (Cabozantinib-SM..

Chiropa chinotamisa, Chiropa chinowanikwa muApollo Chennai

Kuvhiyiwa kenza yechiropa uye kuisirwa naDr.Selvakumar

July 14, 2021: Check out interview of Dr. Selvakumar Naganathan - Clinical Lead - Liver transplantation and HPB surgery, Apollo Hospitals, Chennai. Check out the video and also excerpts of the interview. https://www.youtube.com..

Atezolizumab, Bevacizumab, Dzazvino zvinodhaka

Atezolizumab pamwe neBevacizumab yekurapa kenza yechiropa

Chikunguru 13th 2021: Mushonga wenhau wevanhu vane mhando yegomarara rechiropa inonzi hepatocellular carcinoma inowanikwa inowanikwa inoita kunge iri nani pane yakajairwa kurapwa (HCC) Chikafu neDrug Administration (FDA) yakatenderwa atezoliz ..

CABOMETYX, Cabozantinib, Exelixis, FDA, HCC, hepatocellular carcinoma, Sorafenib, USFDA

Cabozantinib is FDA-inogamuchirwa yehepatocellular carcinoma

  Musi waNdira 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) yakabvumidzwa neFood and Drug Administration kune varwere vane hepatocellular carcinoma (HCC) vakamborapwa sorafenib. The appr..

Kurapa kenza yechiropa mu2023

Kuremerwa kwegomarara rechiropa Gomarara rechiropa ndiro rinowanzoipa bundu rinotora inopfuura hafu yegomarara rechiropa repasi rose. Kutanga kwehepatocellular carcinoma (HCC) yakavanzwa, uye zviratidzo zvekutanga hazvisi pachena. Vanhu vazhinji ..

Yazvino immunotherapy mukurapa kenza yechiropa

Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is mainly sorafenib, but usually only prolongs the overall survival of 3 mont..

NK Cell immunotherapy mune yakakwira cancer kenza kesi

Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s, was diagnosed with hepatocellular carcinoma (caused by cancer in the p..